Skip to main content
. 2022 Oct 13;14(20):5007. doi: 10.3390/cancers14205007

Figure 6.

Figure 6

(a). 3-year OS of patients grouped based on PSMB9 gene expression p = 0.59). (b). 3-year OS of patients grouped based on M1/M2 ratio (p = 0.21). (c) 3-year OS of patients based on CD8+/PSMB9 ratio (p = 0.032).